+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nutraceuticals CDMO Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Softgel), By Services (Product Formulation & Development, Research & Development), By Company Size, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 175 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5830921
Description Jump to:
The global nutraceuticals CDMO market size is expected to reach USD 67.83 billion by 2030, expanding at 7.7% CAGR from 2023 to 2030. Rising awareness of nutraceuticals products, demand for nutraceuticals with medical benefits, and technological advancement are the some of the major factors driving the market growth.

Furthermore, increasing demand for organic and natural products is expected to drive market growth. CDMOs are responding to this demand by providing services related to sustainable manufacturing practices, natural ingredient sourcing, and certifications for organic product manufacturing. Moreover, increasing technological advancements to improve manufacturing processes and enhance product quality is anticipated to create growth opportunities for market growth. The technological advancement includes the adoption of new delivery systems, such as microencapsulation, and nano-emulsions, to improve the bioavailability and stability of nutraceutical ingredients.

Nutraceutical CDMOs are witnessing an increasing demand for customized solutions to meet the specific requirements of individual customers. Key companies are providing personalized nutrition solutions based on a person's unique health and well-being requirements. This is accomplished by lifestyle assessments, genetic testing, and personalized recommendations. Moreover, companies are exploring new delivery systems for nutraceuticals, such as nanoparticle delivery and liposome encapsulation to enhance the efficacy of the products.

On the other hand, key companies in the market undertaking various strategic initiatives such as partnerships, new service launches, mergers and acquisitions, and regional expansion to strengthen their market presence. For instance, in August 2022, Zerion Pharma entered into a partnership with Hovione to cover the use of the Dispersome platform in nutraceuticals. As part of this initiative, Hovione and ZERION will use the Dispersome technology to scale up and create commercial formulations of the antioxidant. Moreover, in October 2019, Sirio Pharma, a China-based nutraceutical contract development organization launched a plant-based nutraceutical service package. The company is actively promoting its integrated solutions for plant-based nutraceuticals through the event.

Nutraceuticals CDMO Market Report Highlights

  • Based on dosage forms, the tablets & capsules segment dominated the market share of 61.43% in 2022. The growth of the segment is attributed to the formulation flexibility it offers to developers. Capsules are available in different sizes (000 to 5), offering developers with various dosing options
  • On the other hand, the soft gel segment is expected to hold a significant market share in the coming years. For individuals who have trouble swallowing tablets or are averse to the idea of injections, the soft gel remains a preferred option because they are simple to take
  • Based on services, manufacturing, and packaging captured a major share in 2022. Manufacturing requires substantial equipment, infrastructure, and skilled staff. By outsourcing these functions to CDMOs, nutraceutical companies can minimize capital expenses and operational expenses associated with maintaining in-house production capabilities
  • Mid-sized companies held a major share of the company size segment in 2022. Mid-sized companies can provide specialized services based on the unique requirements of their customers. Mid-sized CROs can quickly adapt to changing client needs and offer individualized solutions
  • North America dominated the market in 2022 due to factors such as rising awareness regarding nutraceuticals,changing lifestyles, and growing health concerns among consumers
  • Some of the major players include Catalent Inc.; Lonza; NUTRASCIENCE LABS; Robinson Pharma, Inc.; Health Wright Products, Inc.; Innovations in Nutrition + Wellness; among others.

Table of Contents

Chapter 1. Research Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Dosage Form
1.1.3. Company Size
1.1.4. Services
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective-1
1.4.2. Objective-2
1.4.3. Objective-3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Nutraceuticals CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Demand For Nutraceuticals & Rising Outsourcing Of R&D Activities
3.2.1.2. Advancement In Technology
3.2.1.3. Favorable Government Regulations
3.2.2. Market Restraint Analysis
3.2.2.1. Limited availability of Raw materials
3.2.2.2. High production costs and regulatory challenges
3.3. Nutraceuticals CDMO Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Nutraceuticals CDMO Market: Dosage Form Estimates & Trend Analysis
4.1. Nutraceuticals CDMO Market, By Dosage Form: Segment Dashboard
4.2. Nutraceuticals CDMO Market, By Dosage Form: Movement Analysis
4.3. Nutraceuticals CDMO Market Estimates & Forecasts, By Dosage Form, 2018 - 2030
4.3.1. Tablets & Capsules
4.3.1.1. Tablets & Capsules Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
4.3.2. Powder
4.3.2.1. Powder Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
4.3.3. Softgel
4.3.3.1. Softgel Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
4.3.4. Others
4.3.4.1. Others Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
Chapter 5. Nutraceuticals CDMO Market: Services Estimates & Trend Analysis
5.1. Nutraceuticals CDMO Market, By Services: Segment Dashboard
5.2. Nutraceuticals CDMO Market, By Services: Movement Analysis
5.3. Nutraceuticals CDMO Market Estimates & Forecasts, By Services, 2018 - 2030
5.3.1. Product Formulation and Development
5.3.1.1. Product Formulation and Development Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
5.3.2. Manufacturing and Packaging
5.3.2.1. Manufacturing and Packaging Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
5.3.3. Research & Development (R&D)
5.3.3.1. Research & Development (R&D) Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
5.3.4. Regulatory Compliance
5.3.4.1. Regulatory Compliance Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
5.3.5. Others
5.3.5.1. Others Nutraceuticals CDMO Market, 2018 to 2030 (USD Million)
Chapter 6. Nutraceuticals CDMO Market: Company Size Estimates & Trend Analysis
6.1. Nutraceuticals CDMO Market, By Company Size: Segment Dashboard
6.2. Nutraceuticals CDMO Market, By Company Size: Movement Analysis
6.3. Nutraceuticals CDMO Market Estimates & Forecasts, By Company Size, 2018 - 2030
6.3.1. Small Companies
6.3.1.1. Small Companies Nutraceuticals CDMO Market 2018 to 2030 (USD Million)
6.3.2. Mid-Sized Companies
6.3.2.1. Mid-Sized Companies Nutraceuticals CDMO Market 2018 to 2030 (USD Million)
6.3.3. Large Companies
6.3.3.1. Large Companies Nutraceuticals CDMO Market 2018 to 2030 (USD Million)
Chapter 7. Nutraceuticals CDMO Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2022 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Framework
7.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Framework
7.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
7.5. Europe
7.5.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. France Market Estimates and Forecasts, 2018 - 2030
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Framework
7.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Framework
7.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030
7.6. Asia Pacific
7.6.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030
7.6.3. India
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. India Market Estimates and Forecasts, 2018 - 2030
7.6.4. China
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. China Market Estimates and Forecasts, 2018 - 2030
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. South Korea Market Estimates and Forecasts, 2018 - 2030
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Australia Market Estimates and Forecasts, 2018 - 2030
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Thailand Market Estimates and Forecasts, 2018 - 2030
7.7. Latin America
7.7.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
7.7.3. Mexico
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Mexico Market Estimates and Forecasts, 2018 - 2030
7.7.4. Argentina
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. Argentina Market Estimates and Forecasts, 2018 - 2030
7.8. MEA
7.8.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.1.1. Innovators
8.1.2. Market Leaders
8.1.3. Emerging Players
8.1.4. Company Market Share Analysis, 2022
8.2. Company Profiles
8.2.1. Catalent Inc.
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Service Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. Lonza Group AG
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Service Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. Nutrascience Labs
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Service Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Robison Pharma, Inc.
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Service Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Health Wright Products
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Service Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. Innovations in Nutrition + Wellness
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Service Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. INPHARMA S.p.A.
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Service Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. Aenova Group
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Service Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. NutraPakUSA
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Service Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. SFI Health Solutions
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Service Benchmarking
8.2.10.4. Strategic Initiatives
8.3. List of Private Players
Chapter 9. Key Takeaways/ KoL Commentary
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America Nutraceuticals CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 4 North America Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 5 North America Nutraceuticals CDMO Market, by Services, 2018 - 2030 (USD Million)
Table 6 North America Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 7 U.S. Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 8 U.S. Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 9 U.S. Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 10 Canada Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 11 Canada Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 12 Canada Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 13 Europe Nutraceuticals CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 14 Europe Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 15 Europe Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 16 Europe Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 17 UK Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 18 UK Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 19 UK Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 20 Germany Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 21 Germany Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 22 Germany Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 23 France Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 24 France Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 25 France Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 26 Italy Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 27 Italy Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 28 Italy Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 29 Spain Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 30 Spain Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 31 Spain Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 32 Denmark Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 33 Denmark Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 34 Denmark Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 35 Sweden Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 36 Sweden Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 37 Sweden Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 38 Norway Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 39 Norway Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 40 Norway Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 41 Asia Pacific Nutraceuticals CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 42 Asia Pacific Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 43 Asia Pacific Nutraceuticals CDMO Market, by Services, 2018 - 2030 (USD Million)
Table 44 Asia Pacific Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 45 China Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 46 China Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 47 China Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 48 Japan Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 49 Japan Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 50 Japan Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 51 India Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 52 India Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 53 India Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 54 Australia Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 55 Australia Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 56 Australia Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 57 South Korea Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 58 South Korea Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 59 South Korea Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 60 Thailand Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 61 Thailand Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 62 Latin America Nutraceuticals CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 63 Latin America Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 64 Latin America Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 65 Latin America Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 66 Brazil Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 67 Brazil Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 68 Brazil Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 69 Mexico Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 70 Mexico Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 71 Mexico Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 72 Argentina Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 73 Argentina Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 74 Argentina Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa Nutraceuticals CDMO Market, by Region, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 78 Middle East and Africa Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 79 South Africa Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 80 South Africa Nutraceuticals CDMO Market, by Services , 2018 - 2030 (USD Million)
Table 81 South Africa Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia Nutraceuticals CDMO Market, by Services, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 85 UAE Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 86 UAE Nutraceuticals CDMO Market, by Services, 2018 - 2030 (USD Million)
Table 87 UAE Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
Table 88 Kuwait Nutraceuticals CDMO Market, by Dosage Form Type, 2018 - 2030 (USD Million)
Table 89 Kuwait Nutraceuticals CDMO Market, by Services, 2018 - 2030 (USD Million)
Table 90 Kuwait Nutraceuticals CDMO Market, by Company Size, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market research approaches
Fig. 4 QFD modeling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Primary research pattern
Fig. 8 Primary interviews in North America
Fig. 9 Primary Interviews in Europe
Fig. 10 Primary interviews in Asia Pacific
Fig. 11 Primary interviews in Latin America
Fig. 12 Primary interviews in MEA
Fig. 13 Market Snapshot
Fig. 14 Segment Snapshot
Fig. 15 Segment Snapshot
Fig. 16 Competitive Landscape Snapshot
Fig. 17 Nutraceuticals CDMO market segmentation
Fig. 18 Parent market outlook (2022)
Fig. 19 Related/ancillary market outlook (2022)
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Current shared services and outsourcing usage levels
Fig. 22 Market restraint relevance analysis (Current & future impact)
Fig. 23 Porter’s five forces analysis
Fig. 24 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 25 Nutraceuticals CDMO Market Dosage Form outlook: Segment dashboard
Fig. 26 Nutraceuticals CDMO: Dosage Form movement analysis
Fig. 27 Tablets market, 2018 - 2030 (USD Million)
Fig. 28 Powder market, 2018 - 2030 (USD Million)
Fig. 29 Softgel market, 2018 - 2030 (USD Million)
Fig. 30 Others market, 2018 - 2030 (USD Million)
Fig. 31 Nutraceuticals CDMO Market Services outlook: Segment dashboard
Fig. 32 Nutraceuticals CDMO: Services type movement analysis
Fig. 33 Product Formulation and Development Market, 2018 - 2030 (USD Million)
Fig. 34 Manufacturing and Packaging market, 2018 - 2030 (USD Million)
Fig. 35 Research and Development (R&D) market, 2018 - 2030 (USD Million)
Fig. 36 Regulatory Compliance market, 2018 - 2030 (USD Million)
Fig. 37 Others market, 2018 - 2030 (USD Million)
Fig. 38 Nutraceuticals CDMO market Company Size outlook: Segment dashboard
Fig. 39 Nutraceuticals CDMO market: Company Size movement analysis
Fig. 40 Small Companies market, 2018 - 2030 (USD Million)
Fig. 41 Mid-sized Companies market, 2018 - 2030 (USD Million)
Fig. 42 Large Companies Market, 2018 - 2030 (USD Million)
Fig. 43 Regional marketplace: Segment dashboard
Fig. 44 Regional outlook, 2022 & 2030
Fig. 45 North America market, 2018 - 2030 (USD Million)
Fig. 46 U.S. market, 2018 - 2030 (USD Million)
Fig. 47 Canada market, 2018 - 2030 (USD Million)
Fig. 48 Europe market, 2018 - 2030 (USD Million)
Fig. 49 Germany market, 2018 - 2030 (USD Million)
Fig. 50 UK market, 2018 - 2030 (USD Million)
Fig. 51 France market, 2018 - 2030 (USD Million)
Fig. 52 Italy market, 2018 - 2030 (USD Million)
Fig. 53 Spain market, 2018 - 2030 (USD Million)
Fig. 54 Denmark market, 2018 - 2030(USD Million)
Fig. 55 Sweden market, 2018 - 2030 (USD Million)
Fig. 56 Norway market, 2018 - 2030 (USD Million)
Fig. 57 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 58 China market, 2018 - 2030 (USD Million)
Fig. 59 Japan market, 2018 - 2030 (USD Million)
Fig. 60 India market, 2018 - 2030 (USD Million)
Fig. 61 Australia market, 2018 - 2030 (USD Million)
Fig. 62 South Korea market, 2018 - 2030 (USD Million)
Fig. 63 Latin America market, 2018 - 2030 (USD Million)
Fig. 64 Brazil market, 2018 - 2030 (USD Million)
Fig. 65 Mexico market, 2018 - 2030 (USD Million)
Fig. 66 Argentina market, 2018 - 2030 (USD Million)
Fig. 67 Middle East & Africa market, 2018 - 2030 (USD Million)
Fig. 68 South Africa market, 2018 - 2030 (USD Million)
Fig. 69 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 70 UAE market, 2018 - 2030 (USD Million)
Fig. 71 Kuwait market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Catalent Inc.
  • Lonza Group AG
  • Nutrascience Labs
  • Robison Pharma, Inc.
  • Health Wright Products
  • Innovations in Nutrition + Wellness
  • INPHARMA S.p.A.
  • Aenova Group
  • NutraPakUSA
  • SFI Health Solutions

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages175
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 37.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 67.83 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 190 Pages
  • Global
From
Advanced Therapy Medicinal Products CDMO Market Size, Share & Trends Analysis Report by Product (Gene Therapy, Cell Therapy), Phase, Indication, Region, and Segment Forecasts, 2024-2030 - Product Image

Advanced Therapy Medicinal Products CDMO Market Size, Share & Trends Analysis Report by Product (Gene Therapy, Cell Therapy), Phase, Indication, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Pharmaceutical CDMO Market Size, Share & Trends Analysis Report by Product (API, Drug Product), Workflow (Clinical, Commercial), Application (Oncology, Infectious Diseases, Neurological Disorders), Region, and Segment Forecasts, 2024-2030 - Product Image

Pharmaceutical CDMO Market Size, Share & Trends Analysis Report by Product (API, Drug Product), Workflow (Clinical, Commercial), Application (Oncology, Infectious Diseases, Neurological Disorders), Region, and Segment Forecasts, 2024-2030

  • Report
  • 342 Pages
  • Global
From
Nucleic Acid Therapeutics CDMO Market by Type, Service, Application, End-user - Global Forecast 2025-2030 - Product Image

Nucleic Acid Therapeutics CDMO Market by Type, Service, Application, End-user - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Cell & Gene Therapy Biomanufacturing CDMO Market by Component, Phase, Indication - Global Forecast 2025-2030 - Product Image

Cell & Gene Therapy Biomanufacturing CDMO Market by Component, Phase, Indication - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.